BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23690123)

  • 21. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of M protein from filter paper using serum protein and immunofixation electrophoresis.
    Wu Y; Yang X; Wang T; Wang H; Li Z
    Am J Clin Pathol; 2012 Oct; 138(4):604-8. PubMed ID: 23010716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect.
    Shaheen SP; Levinson SS
    Clin Chim Acta; 2009 Aug; 406(1-2):162-6. PubMed ID: 19410572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic accuracy of serum protein electrophoresis and free light chain measurements for monoclonal gammopathies].
    Peña C; Ortiz M; Voisin J; Peralta A; Balboa V; Delgado F
    Rev Med Chil; 2018 Jan; 146(1):64-67. PubMed ID: 29806679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reflexing Suspicious β-Region Findings on Capillary Serum Protein Electrophoresis to Immunofixation or Immunosubtraction for Detecting Monoclonal Proteins.
    Kitson AL; Taylor AS; Giacherio DA; Keren DF
    Am J Clin Pathol; 2022 Feb; 157(2):171-179. PubMed ID: 34519791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis.
    Turner KA; Frinack JL; Ettore MW; Tate JR; Graziani MS; Jacobs JFM; Booth RA; McCudden CR; Keren DF; Delgado JC; Zemtsovskaja G; Fullinfaw RO; Caldini A; de Malmanche T; Katakouzinos K; Burke M; Palladini G; Altinier S; Zaninotto M; Righetti G; Melki MT; Bell S; Willrich MAV
    Clin Chem Lab Med; 2020 Mar; 58(4):533-546. PubMed ID: 31940284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between monoclonal gammopathy and cardiac amyloid type.
    Maleszewski JJ; Murray DL; Dispenzieri A; Grogan M; Pereira NL; Jenkins SM; Judge DP; Caturegli P; Vrana JA; Theis JD; Dogan A; Halushka MK
    Cardiovasc Pathol; 2013; 22(3):189-94. PubMed ID: 23102805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.
    Ludwig H; Milosavljevic D; Zojer N; Faint JM; Bradwell AR; Hübl W; Harding SJ
    Leukemia; 2013 Jan; 27(1):213-9. PubMed ID: 22955329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.
    Katzmann JA; Willrich MA; Kohlhagen MC; Kyle RA; Murray DL; Snyder MR; Rajkumar SV; Dispenzieri A
    Clin Chem; 2015 Feb; 61(2):360-7. PubMed ID: 25451866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of serum free light chains assay in plasma cell disorders].
    López-Corral L; García-Sanz R; San Miguel JF
    Med Clin (Barc); 2010 Sep; 135(8):368-74. PubMed ID: 20598719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening panels for monoclonal gammopathies: time to change.
    Katzmann JA
    Clin Biochem Rev; 2009 Aug; 30(3):105-11. PubMed ID: 19841692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance evaluation of the Helena V8 capillary electrophoresis system.
    Poisson J; Fedoriw Y; Henderson MP; Hainsworth S; Tucker K; Uddin Z; McCudden CR
    Clin Biochem; 2012 Jun; 45(9):697-9. PubMed ID: 22465274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of immunofixation electrophoresis in the clinical laboratory.
    Roberts RT
    Clin Lab Med; 1986 Sep; 6(3):601-5. PubMed ID: 3742987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunofixation electrophoresis was highly specific for the diagnosis of renal light-chain amyloidosis.
    Zhou FD; Zhang LX; Yao Y; Wang SX; Zou WZ; Liu G; Chen M; Zhao MH
    Am J Med Sci; 2013 Jan; 345(1):18-21. PubMed ID: 22627261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of isatuximab-derived interference in serum protein electrophoresis and immunofixation, and an absence of sustained in vivo interference due to belantamab mafodotin and denosumab.
    Jimenez A; Scholl AR; Wang B; Schilke M; Carlsen ED
    Clin Biochem; 2024 May; 127-128():110761. PubMed ID: 38565341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening immunofixation should replace protein electrophoresis as the initial investigation of monoclonal gammopathy: Point.
    Pretorius CJ
    Clin Chem Lab Med; 2016 Jun; 54(6):963-6. PubMed ID: 26574893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of capillary zone and immunosubtraction with agarose gel and immunofixation electrophoresis for detecting and identifying monoclonal gammopathies.
    Litwin CM; Anderson SK; Philipps G; Martins TB; Jaskowski TD; Hill HR
    Am J Clin Pathol; 1999 Sep; 112(3):411-7. PubMed ID: 10478148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.
    Fulton RB; Fernando SL
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):407-12. PubMed ID: 19641008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Casirivimab Plus Imdevimab, Sotrovimab, and Bamlanivimab Plus Etesevimab-Derived Interference in Serum Protein Electrophoresis and Immunofixation Electrophoresis.
    Scholl AR; Korentzelos D; Forns TE; Brenneman EK; Kelm M; Datto M; Wheeler SE; Carlsen ED
    J Appl Lab Med; 2022 Oct; 7(6):1379-1387. PubMed ID: 35993812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins.
    Jacobs JFM; Turner KA; Graziani MS; Frinack JL; Ettore MW; Tate JR; Booth RA; McCudden CR; Keren DF; Delgado JC; Zemtsovskaja G; Fullinfaw RO; Caldini A; de Malmanche T; Katakouzinos K; Burke M; Palladini G; Altinier S; Zaninotto M; Righetti G; Melki MT; Bell S; Willrich MAV
    Clin Chem Lab Med; 2020 Mar; 58(4):547-559. PubMed ID: 31940285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.